Alignment Healthcare, Inc.'s SEC filings document a Medicare Advantage operating company with common stock listed on Nasdaq under ALHC. Its Form 8-K reports furnish quarterly and annual operating results, health plan membership, revenue, adjusted gross profit, adjusted EBITDA, guidance updates and Regulation FD materials related to strategy, market position and Medicare Advantage quality ratings.
Proxy materials cover board elections, executive compensation, equity awards, pay-versus-performance data and shareholder voting matters. Registration statements, prospectus supplements and underwriting agreements describe secondary offerings of common stock by selling stockholders, the company's capital structure and related securities-law obligations.
Alignment Healthcare (ALHC) Chief Medical Officer Hyong (Ken) Kim reported two non-discretionary stock sales tied to restricted stock unit vesting and a pre-existing trading plan. On 10/08/2025 Mr. Kim sold 33,655 shares at $17.29 to cover tax withholding, leaving 413,712 shares prior to the second sale. On 10/09/2025 he sold 51,379 shares at $17.5713, leaving 362,333 shares beneficially owned after the transactions. The Form 4 notes a Rule 10b5-1 trading plan adopted on 03/14/2025, and the filings state these sales were not discretionary trades but routine tax-withholding dispositions tied to RSU vesting.
Form 144 filing for proposed sale of $908,894.51 in common stock (51,379 shares) with an approximate sale date of 10/09/2025. The shares were acquired as Restricted Stock Units on 10/04/2025 and show 51,379 units to be sold through Morgan Stanley Smith Barney LLC Executive Financial Services on NASDAQ. The filing lists 198,031,417 shares outstanding, and records prior 10b5-1 sales by the same account totaling 62,000 shares during August 2025 for aggregate gross proceeds of $946,833.62 across three trades. Certain standard issuer identification fields (issuer name and SEC file number) are not populated in the visible text, so the filing cannot be tied to an issuer by name from this extract.
Alignment Healthcare, Inc. submitted a Form 144 reporting a proposed sale of 35,500 shares of common stock, with an aggregate market value of $602,790. The shares represent a small fraction of the reported 198,031,417 shares outstanding and are scheduled for sale on 10/08/2025 on the Nasdaq Stock Market. The filing shows the securities were acquired on 10/04/2023 through the vesting of restricted stock units granted under the company’s 2021 Equity Incentive Plan. The notice also lists prior Rule 10b5-1 plan sales by the same account totaling 62,000 shares in August 2025 with combined gross proceeds of approximately $946,833. The signer certifies no undisclosed material adverse information.
Qatar Investment Authority and its subsidiary Q Healthcare Holding LLC filed a Schedule 13G reporting ownership of 13,246,096 shares of Alignment Healthcare, Inc. common stock, representing 6.69% of the outstanding shares. The filing states each reporting person has sole voting and sole dispositive power over those shares and that the percent was calculated using 198,031,417 shares outstanding per Alignment Healthcares July 25, 2025 disclosure. The statement includes a joint filing agreement and a certification that the stake was not acquired to influence control of the issuer.
Qatar Investment Authority and its subsidiary Q Healthcare Holding LLC filed a Schedule 13G reporting ownership of 13,246,096 shares of Alignment Healthcare, Inc. common stock, representing 6.69% of the outstanding shares. The filing states each reporting person has sole voting and sole dispositive power over those shares and that the percent was calculated using 198,031,417 shares outstanding per Alignment Healthcares July 25, 2025 disclosure. The statement includes a joint filing agreement and a certification that the stake was not acquired to influence control of the issuer.
Qatar Investment Authority and its subsidiary Q Healthcare Holding LLC filed a Schedule 13G reporting ownership of 13,246,096 shares of Alignment Healthcare, Inc. common stock, representing 6.69% of the outstanding shares. The filing states each reporting person has sole voting and sole dispositive power over those shares and that the percent was calculated using 198,031,417 shares outstanding per Alignment Healthcares July 25, 2025 disclosure. The statement includes a joint filing agreement and a certification that the stake was not acquired to influence control of the issuer.
Qatar Investment Authority and its subsidiary Q Healthcare Holding LLC filed a Schedule 13G reporting ownership of 13,246,096 shares of Alignment Healthcare, Inc. common stock, representing 6.69% of the outstanding shares. The filing states each reporting person has sole voting and sole dispositive power over those shares and that the percent was calculated using 198,031,417 shares outstanding per Alignment Healthcares July 25, 2025 disclosure. The statement includes a joint filing agreement and a certification that the stake was not acquired to influence control of the issuer.
Qatar Investment Authority and its subsidiary Q Healthcare Holding LLC filed a Schedule 13G reporting ownership of 13,246,096 shares of Alignment Healthcare, Inc. common stock, representing 6.69% of the outstanding shares. The filing states each reporting person has sole voting and sole dispositive power over those shares and that the percent was calculated using 198,031,417 shares outstanding per Alignment Healthcares July 25, 2025 disclosure. The statement includes a joint filing agreement and a certification that the stake was not acquired to influence control of the issuer.
Qatar Investment Authority and its subsidiary Q Healthcare Holding LLC filed a Schedule 13G reporting ownership of 13,246,096 shares of Alignment Healthcare, Inc. common stock, representing 6.69% of the outstanding shares. The filing states each reporting person has sole voting and sole dispositive power over those shares and that the percent was calculated using 198,031,417 shares outstanding per Alignment Healthcares July 25, 2025 disclosure. The statement includes a joint filing agreement and a certification that the stake was not acquired to influence control of the issuer.
Qatar Investment Authority and its subsidiary Q Healthcare Holding LLC filed a Schedule 13G reporting ownership of 13,246,096 shares of Alignment Healthcare, Inc. common stock, representing 6.69% of the outstanding shares. The filing states each reporting person has sole voting and sole dispositive power over those shares and that the percent was calculated using 198,031,417 shares outstanding per Alignment Healthcares July 25, 2025 disclosure. The statement includes a joint filing agreement and a certification that the stake was not acquired to influence control of the issuer.
Qatar Investment Authority and its subsidiary Q Healthcare Holding LLC filed a Schedule 13G reporting ownership of 13,246,096 shares of Alignment Healthcare, Inc. common stock, representing 6.69% of the outstanding shares. The filing states each reporting person has sole voting and sole dispositive power over those shares and that the percent was calculated using 198,031,417 shares outstanding per Alignment Healthcares July 25, 2025 disclosure. The statement includes a joint filing agreement and a certification that the stake was not acquired to influence control of the issuer.
Qatar Investment Authority and its subsidiary Q Healthcare Holding LLC filed a Schedule 13G reporting ownership of 13,246,096 shares of Alignment Healthcare, Inc. common stock, representing 6.69% of the outstanding shares. The filing states each reporting person has sole voting and sole dispositive power over those shares and that the percent was calculated using 198,031,417 shares outstanding per Alignment Healthcares July 25, 2025 disclosure. The statement includes a joint filing agreement and a certification that the stake was not acquired to influence control of the issuer.
Qatar Investment Authority and its subsidiary Q Healthcare Holding LLC filed a Schedule 13G reporting ownership of 13,246,096 shares of Alignment Healthcare, Inc. common stock, representing 6.69% of the outstanding shares. The filing states each reporting person has sole voting and sole dispositive power over those shares and that the percent was calculated using 198,031,417 shares outstanding per Alignment Healthcares July 25, 2025 disclosure. The statement includes a joint filing agreement and a certification that the stake was not acquired to influence control of the issuer.
Qatar Investment Authority and its subsidiary Q Healthcare Holding LLC filed a Schedule 13G reporting ownership of 13,246,096 shares of Alignment Healthcare, Inc. common stock, representing 6.69% of the outstanding shares. The filing states each reporting person has sole voting and sole dispositive power over those shares and that the percent was calculated using 198,031,417 shares outstanding per Alignment Healthcares July 25, 2025 disclosure. The statement includes a joint filing agreement and a certification that the stake was not acquired to influence control of the issuer.
Qatar Investment Authority and its subsidiary Q Healthcare Holding LLC filed a Schedule 13G reporting ownership of 13,246,096 shares of Alignment Healthcare, Inc. common stock, representing 6.69% of the outstanding shares. The filing states each reporting person has sole voting and sole dispositive power over those shares and that the percent was calculated using 198,031,417 shares outstanding per Alignment Healthcares July 25, 2025 disclosure. The statement includes a joint filing agreement and a certification that the stake was not acquired to influence control of the issuer.
Qatar Investment Authority and its subsidiary Q Healthcare Holding LLC filed a Schedule 13G reporting ownership of 13,246,096 shares of Alignment Healthcare, Inc. common stock, representing 6.69% of the outstanding shares. The filing states each reporting person has sole voting and sole dispositive power over those shares and that the percent was calculated using 198,031,417 shares outstanding per Alignment Healthcares July 25, 2025 disclosure. The statement includes a joint filing agreement and a certification that the stake was not acquired to influence control of the issuer.
Qatar Investment Authority and its subsidiary Q Healthcare Holding LLC filed a Schedule 13G reporting ownership of 13,246,096 shares of Alignment Healthcare, Inc. common stock, representing 6.69% of the outstanding shares. The filing states each reporting person has sole voting and sole dispositive power over those shares and that the percent was calculated using 198,031,417 shares outstanding per Alignment Healthcares July 25, 2025 disclosure. The statement includes a joint filing agreement and a certification that the stake was not acquired to influence control of the issuer.
Qatar Investment Authority and its subsidiary Q Healthcare Holding LLC filed a Schedule 13G reporting ownership of 13,246,096 shares of Alignment Healthcare, Inc. common stock, representing 6.69% of the outstanding shares. The filing states each reporting person has sole voting and sole dispositive power over those shares and that the percent was calculated using 198,031,417 shares outstanding per Alignment Healthcares July 25, 2025 disclosure. The statement includes a joint filing agreement and a certification that the stake was not acquired to influence control of the issuer.
Qatar Investment Authority and its subsidiary Q Healthcare Holding LLC filed a Schedule 13G reporting ownership of 13,246,096 shares of Alignment Healthcare, Inc. common stock, representing 6.69% of the outstanding shares. The filing states each reporting person has sole voting and sole dispositive power over those shares and that the percent was calculated using 198,031,417 shares outstanding per Alignment Healthcares July 25, 2025 disclosure. The statement includes a joint filing agreement and a certification that the stake was not acquired to influence control of the issuer.
Qatar Investment Authority and its subsidiary Q Healthcare Holding LLC filed a Schedule 13G reporting ownership of 13,246,096 shares of Alignment Healthcare, Inc. common stock, representing 6.69% of the outstanding shares. The filing states each reporting person has sole voting and sole dispositive power over those shares and that the percent was calculated using 198,031,417 shares outstanding per Alignment Healthcares July 25, 2025 disclosure. The statement includes a joint filing agreement and a certification that the stake was not acquired to influence control of the issuer.
Qatar Investment Authority and its subsidiary Q Healthcare Holding LLC filed a Schedule 13G reporting ownership of 13,246,096 shares of Alignment Healthcare, Inc. common stock, representing 6.69% of the outstanding shares. The filing states each reporting person has sole voting and sole dispositive power over those shares and that the percent was calculated using 198,031,417 shares outstanding per Alignment Healthcares July 25, 2025 disclosure. The statement includes a joint filing agreement and a certification that the stake was not acquired to influence control of the issuer.
Qatar Investment Authority and its subsidiary Q Healthcare Holding LLC filed a Schedule 13G reporting ownership of 13,246,096 shares of Alignment Healthcare, Inc. common stock, representing 6.69% of the outstanding shares. The filing states each reporting person has sole voting and sole dispositive power over those shares and that the percent was calculated using 198,031,417 shares outstanding per Alignment Healthcares July 25, 2025 disclosure. The statement includes a joint filing agreement and a certification that the stake was not acquired to influence control of the issuer.
Qatar Investment Authority and its subsidiary Q Healthcare Holding LLC filed a Schedule 13G reporting ownership of 13,246,096 shares of Alignment Healthcare, Inc. common stock, representing 6.69% of the outstanding shares. The filing states each reporting person has sole voting and sole dispositive power over those shares and that the percent was calculated using 198,031,417 shares outstanding per Alignment Healthcares July 25, 2025 disclosure. The statement includes a joint filing agreement and a certification that the stake was not acquired to influence control of the issuer.
Qatar Investment Authority and its subsidiary Q Healthcare Holding LLC filed a Schedule 13G reporting ownership of 13,246,096 shares of Alignment Healthcare, Inc. common stock, representing 6.69% of the outstanding shares. The filing states each reporting person has sole voting and sole dispositive power over those shares and that the percent was calculated using 198,031,417 shares outstanding per Alignment Healthcares July 25, 2025 disclosure. The statement includes a joint filing agreement and a certification that the stake was not acquired to influence control of the issuer.
Qatar Investment Authority and its subsidiary Q Healthcare Holding LLC filed a Schedule 13G reporting ownership of 13,246,096 shares of Alignment Healthcare, Inc. common stock, representing 6.69% of the outstanding shares. The filing states each reporting person has sole voting and sole dispositive power over those shares and that the percent was calculated using 198,031,417 shares outstanding per Alignment Healthcares July 25, 2025 disclosure. The statement includes a joint filing agreement and a certification that the stake was not acquired to influence control of the issuer.
Qatar Investment Authority and its subsidiary Q Healthcare Holding LLC filed a Schedule 13G reporting ownership of 13,246,096 shares of Alignment Healthcare, Inc. common stock, representing 6.69% of the outstanding shares. The filing states each reporting person has sole voting and sole dispositive power over those shares and that the percent was calculated using 198,031,417 shares outstanding per Alignment Healthcares July 25, 2025 disclosure. The statement includes a joint filing agreement and a certification that the stake was not acquired to influence control of the issuer.
Qatar Investment Authority and its subsidiary Q Healthcare Holding LLC filed a Schedule 13G reporting ownership of 13,246,096 shares of Alignment Healthcare, Inc. common stock, representing 6.69% of the outstanding shares. The filing states each reporting person has sole voting and sole dispositive power over those shares and that the percent was calculated using 198,031,417 shares outstanding per Alignment Healthcares July 25, 2025 disclosure. The statement includes a joint filing agreement and a certification that the stake was not acquired to influence control of the issuer.
Qatar Investment Authority and its subsidiary Q Healthcare Holding LLC filed a Schedule 13G reporting ownership of 13,246,096 shares of Alignment Healthcare, Inc. common stock, representing 6.69% of the outstanding shares. The filing states each reporting person has sole voting and sole dispositive power over those shares and that the percent was calculated using 198,031,417 shares outstanding per Alignment Healthcares July 25, 2025 disclosure. The statement includes a joint filing agreement and a certification that the stake was not acquired to influence control of the issuer.
General Atlantic and affiliated funds report beneficial ownership of 24,287,227 shares of Alignment Healthcare Class A common stock, representing 12.3% of the outstanding shares. The filing states the percentage is calculated using 198,031,417 shares outstanding as reported by the company in its quarterly report filed July 30, 2025. The shares are held by General Atlantic (ALN HLTH), L.P. (GA ALN) and beneficial ownership is shared across multiple General Atlantic entities and funds, with shared voting and dispositive power reported for 24,287,227 shares and no sole voting or dispositive power reported. The filing explains the intercompany relationships (general partners and managing members) that give rise to shared control and notes Michael Gosk signed on behalf of the reporting persons on September 24, 2025.
General Atlantic and affiliated funds report beneficial ownership of 24,287,227 shares of Alignment Healthcare Class A common stock, representing 12.3% of the outstanding shares. The filing states the percentage is calculated using 198,031,417 shares outstanding as reported by the company in its quarterly report filed July 30, 2025. The shares are held by General Atlantic (ALN HLTH), L.P. (GA ALN) and beneficial ownership is shared across multiple General Atlantic entities and funds, with shared voting and dispositive power reported for 24,287,227 shares and no sole voting or dispositive power reported. The filing explains the intercompany relationships (general partners and managing members) that give rise to shared control and notes Michael Gosk signed on behalf of the reporting persons on September 24, 2025.
General Atlantic and affiliated funds report beneficial ownership of 24,287,227 shares of Alignment Healthcare Class A common stock, representing 12.3% of the outstanding shares. The filing states the percentage is calculated using 198,031,417 shares outstanding as reported by the company in its quarterly report filed July 30, 2025. The shares are held by General Atlantic (ALN HLTH), L.P. (GA ALN) and beneficial ownership is shared across multiple General Atlantic entities and funds, with shared voting and dispositive power reported for 24,287,227 shares and no sole voting or dispositive power reported. The filing explains the intercompany relationships (general partners and managing members) that give rise to shared control and notes Michael Gosk signed on behalf of the reporting persons on September 24, 2025.
General Atlantic and affiliated funds report beneficial ownership of 24,287,227 shares of Alignment Healthcare Class A common stock, representing 12.3% of the outstanding shares. The filing states the percentage is calculated using 198,031,417 shares outstanding as reported by the company in its quarterly report filed July 30, 2025. The shares are held by General Atlantic (ALN HLTH), L.P. (GA ALN) and beneficial ownership is shared across multiple General Atlantic entities and funds, with shared voting and dispositive power reported for 24,287,227 shares and no sole voting or dispositive power reported. The filing explains the intercompany relationships (general partners and managing members) that give rise to shared control and notes Michael Gosk signed on behalf of the reporting persons on September 24, 2025.
General Atlantic (ALN HLTH), L.P. sold 6,246,096 shares of Alignment Healthcare, Inc. (ALHC) on 09/17/2025 at $16.01 per share in a private placement, reducing the reporting entity's direct holdings to 24,287,227 shares. After the transaction, GA ALN reports indirect additional holdings of 135,716 shares and 18,710 restricted stock units held for two individuals for the benefit of General Atlantic Service Company, L.P. The filing identifies GA ALN and several affiliated General Atlantic funds and entities that may constitute a group but disclaims ownership beyond direct holdings. The Form 4 is signed by Michael Gosk on 09/19/2025.
General Atlantic (ALN HLTH), L.P. sold 6,246,096 shares of Alignment Healthcare, Inc. (ALHC) on 09/17/2025 at $16.01 per share in a private placement, reducing the reporting entity's direct holdings to 24,287,227 shares. After the transaction, GA ALN reports indirect additional holdings of 135,716 shares and 18,710 restricted stock units held for two individuals for the benefit of General Atlantic Service Company, L.P. The filing identifies GA ALN and several affiliated General Atlantic funds and entities that may constitute a group but disclaims ownership beyond direct holdings. The Form 4 is signed by Michael Gosk on 09/19/2025.
General Atlantic entities reported a private sale of Alignment Healthcare common stock. On 09/17/2025, General Atlantic (ALN HLTH), L.P. sold 6,246,096 shares of ALHC at $16.01 per share in a private placement to a third party.
After the transaction GA ALN held 24,287,227 shares directly and, including certain shares and restricted stock units held for the benefit of General Atlantic Service Company, L.P., the reporting group beneficially owned 24,596,079 shares indirectly. Multiple General Atlantic affiliated entities are listed as reporting persons and may be deemed members of a group; each disclaimers ownership beyond direct holdings.
General Atlantic entities reported a private sale of Alignment Healthcare common stock. On 09/17/2025, General Atlantic (ALN HLTH), L.P. sold 6,246,096 shares of ALHC at $16.01 per share in a private placement to a third party.
After the transaction GA ALN held 24,287,227 shares directly and, including certain shares and restricted stock units held for the benefit of General Atlantic Service Company, L.P., the reporting group beneficially owned 24,596,079 shares indirectly. Multiple General Atlantic affiliated entities are listed as reporting persons and may be deemed members of a group; each disclaimers ownership beyond direct holdings.
Joseph S. Konowiecki, a director of Alignment Healthcare, Inc. (ALHC), reported a non-discretionary sale of 16,076 shares of common stock on 09/16/2025 at a price of $16.24 per share. The sale represents shares withheld to satisfy tax withholding obligations tied to the vesting of restricted stock units and is explicitly described as not a discretionary trade. After the transaction, the reporting person beneficially owned 1,110,973 shares, held directly. The filing discloses routine insider tax-related share withholding rather than an open-market decision to reduce ownership.
General Atlantic (ALN HLTH), L.P. reported an open-market sale of 13,460,000 shares of Alignment Healthcare, Inc. (ALHC) that settled on 09/12/2025 at a net price of $16.01 per share. Following the transaction, GA ALN directly held 30,533,323 shares. The filing reports 30,842,175 shares beneficially owned in total on an indirect basis, which reflects additional shares and restricted stock units held by two individuals for the benefit of General Atlantic Service Company, L.P. The reporting entity is listed as both a director and a 10% owner. The form is signed by Michael Gosk on 09/16/2025.
General Atlantic reported an open-market sale of 13,460,000 shares of Alignment Healthcare (ALHC) common stock settled on 09/12/2025 at a net price of $16.01 per share. After the transaction, General Atlantic (GA ALN) held 30,533,323 shares directly and, when combined with certain shares and restricted stock units held for the benefit of General Atlantic Service Company, L.P., the reporting group is shown as beneficially owning 30,842,175 shares in the filing. The Form 4 identifies multiple related General Atlantic entities and states they may be deemed a group while disclaiming broader beneficial ownership. The filing is signed by Michael Gosk on 09/16/2025 and lists the reporting persons as directors-by-deputization for Section 16 purposes.